Brief: Guard Therapeutics Completes Pre-IND Meeting With FDA
Dec 29 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* GUARD THERAPEUTICS COMPLETES SUCCESSFUL PRE-IND MEETING
WITH FDA
* COMPLETED A PRE-IND MEETING WITH US FOOD AND DRUG
ADMINISTRATION
AND HAS RECEIVED POSITIVE FEEDBACK ON ITS PLANNED CLINICAL
DEVELOPMENT PROGRAMME FOR ITS INVESTIGATIONAL DRUG ROSGARD
Source text for Eikon: ID:nMFN6RLKx
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover